Injection, Suspension · Intramuscular
Influenza A Virus A/Switzerland/6849/2025 Ivr-278 (H1n1) Antigen (Formaldehyde Inactivated), Influenza A Virus A/Michigan/105/2025 San-049a (H3n2) Antigen (Formaldehyde Inactivated), And Influenza B Virus B/Tokyo/Eis13-175/2025 Antigen (Formaldehyde Inactivated)
Brands: Fluzone Trivalent Northern Hemisphere · Influenza A Virus A/Switzerland/6849/2025 Ivr-278 (H1n1) Antigen (Formaldehyde Inactivated) + Influenza A Virus A/Michigan/105/2025 San-049a (H3n2) Antigen (Formaldehyde Inactivated) + Influenza B Virus B/Tokyo/Eis13-175/2025 Antigen (Formaldehyde Inactivated)
0 ACTIVE SUPPLIERS - US
openFDA · updated weekly
US2 NDCs
0 active makers
0 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC -
RxCUI (US)2738127
US makers1 labelers
Packages2
DEA / ScheduleNone
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sanofi Vaccines US Inc. | unknown | 2 | EXITED 2027 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.